Genvor Inc
A loss-making micro-cap tech entity with zero revenue, massive dilution, and negative shareholders equity trading on the OTC.
A loss-making micro-cap tech entity with zero revenue, massive dilution, and negative shareholders equity trading on the OTC.
A bullish case rests on the potential for a paradigm shift where current R&D investments ($456k) finally translate into a breakthrough commercial product, turning the current zero-revenue model into a high-growth engine. The company's ability to secure financing and maintain operations suggests a management team capable of navigating capital markets in the micro-cap space. If a viable market fit is achieved, the negative equity could be viewed as an asset write-down rather than a terminal value indicator.
The stock is a bearish candidate due to the confirmed lack of revenue generation and a deteriorating net income trend from positive $1.7M in 2023 to -$5.6M recently. The balance sheet is fragile with current liabilities ($1.4M) dwarfing current assets ($45k), creating an imminent solvency threat if financing dries up. Continued reliance on share issuances to cover operating deficits will likely lead to further dilution without any corresponding increase in earnings power.
Genvor Inc. (GNVR) is a micro-cap technology firm operating with negligible revenue but significant non-cash adjustments and share-based compensation. The company reports substantial losses driven by high operating expenses and interest costs while maintaining minimal cash reserves on the OTC market. Financials indicate heavy reliance on capital raises to fund research and development rather than organic commercial growth.
Management's recent performance analysis reveals a deepening deficit trend, moving from a $1.7M profit in 2023 to a $-5.6M loss in the latest period of 2025. This deterioration is driven by operating expenses climbing to $6.4M while revenue remains at zero, indicating a failure to monetize R&D efforts or secure commercial contracts. The company's cash flow from financing ($592k) was essential but insufficient to cover the net change in cash and operational burn.
The company operates in a speculative technology sector where early-stage firms often burn cash through R&D before achieving commercial viability, yet GNVR has failed to generate any sales after five years. The industry typically rewards successful product launches but penalizes prolonged periods of zero revenue and negative cash flows as seen in this firm's trajectory. Success in this niche requires transitioning from a research-focused model to a revenue-generating one to attract institutional interest.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| Operating Expenses | $4.3M | $1.4M | $2.8M | $6.4M |
| Operating Income | $-4.3M | $-1.4M | $-2.8M | $-6.4M |
| R&D | $246.5K | — | $240.3K | $455.9K |
| Stock-Based Comp | $3.5M | $977.2K | $1.4M | $4.9M |
| D&A | $1.4K | — | — | — |
| Depreciation | — | $1.8K | $1.8K | $1.4K |
| Other OpEx | $4.0M | — | $2.5M | $6.0M |
| Non-Operating Income | $0 | $0 | $-101.9K | $820.8K |
| Interest Expense | — | $43.8K | $17.7K | $59.8K |
| Pre-Tax Income | $-4.3M | $-1.4M | $-2.9M | $-5.6M |
| Income Tax | $0 | $-3.1M | $42 | $-41 |
| Continuing Ops | $-4.3M | $1.7M | $-2.9M | $-5.6M |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $-4.5M | $1.7M | $-2.9M | $-5.6M |
| Minority Interest | $0 | $0 | $0 | $0 |
| Net to Common | $-4.5M | $1.7M | $-2.9M | $-5.6M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $298.4K | $66.3K | $21.7K | $45.8K |
| Long-Term Assets | $17.6K | $15.7K | $13.9K | $0 |
| PP&E (Net) | $17.6K | $15.7K | $13.9K | — |
| Other LT Assets | $1 | $0 | $0 | — |
| Total Assets | $316.0K | $82.1K | $35.6K | $45.8K |
| Current Liabilities | $1.9M | $1.8M | $1.7M | $1.4M |
| Accounts Payable | $516.7K | — | — | — |
| Other Current Liab | $1.4M | — | $1.7M | $1.3M |
| Long-Term Liabilities | $89.2K | $0 | $0 | $0 |
| Total Liabilities | $2.0M | $1.8M | $1.7M | $1.4M |
| Shareholders' Equity | $-1.6M | $-1.7M | $-1.7M | $-1.3M |
| Paid-In Capital | $14.6M | $16.3M | $19.2M | $25.1M |
| Retained Earnings | $-16.3M | $-17.7M | $-20.6M | $-26.2M |
| Treasury Stock | — | $300.0K | $300.0K | $300.0K |
| Total L&E | $316.0K | $82.1K | $35.6K | $45.8K |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $-4.5M | $1.7M | $-2.9M | $-5.6M |
| Non-Cash Adjustments | $3.9M | $-2.1M | $1.9M | $4.2M |
| Working Capital Changes | $-5.2K | $-504.7K | $1.4K | $840.5K |
| Cash from Operations | $-553.2K | $-871.7K | $-975.6K | $-555.7K |
| Cash from Investing | $0 | $0 | $0 | $0 |
| Cash from Financing | $465.0K | $619.7K | $931.7K | $592.6K |
| FX Effect | $0 | $0 | $0 | $0 |
| Net Change in Cash | $-88.2K | $-252.0K | $-44.0K | $36.9K |
| Beginning Cash | $384.6K | $296.4K | $44.4K | $373 |
| Ending Cash | $296.4K | $44.4K | $373 | $37.2K |
The company's financial structure suggests a single speculative segment focused on R&D or early-stage technology development with no current commercial product lines generating revenue. Operations are characterized by non-operating income losses that offset minimal operational costs, resulting in total revenue of zero for the latest reporting period.
The primary risk is severe liquidity distress, evidenced by a $1.4M liability load against only $37K in ending cash and a $26.2M retained earnings deficit. Investors face extreme dilution risk as the company has issued common shares worth $525,000 recently to fund operations. There is also high financial leverage risk with interest expenses exceeding $59k despite having no current revenue stream.
The firm possesses a competitive advantage through high research and development spending relative to its size, aiming to secure future intellectual property or proprietary technology. Additionally, the company utilizes significant share-based compensation ($4.9M) to align employee incentives with potential long-term value creation despite current profitability challenges.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.